
Sean E. Aeder
Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1939 |
| Issued Applications | 907 |
| Pending Applications | 201 |
| Abandoned Applications | 855 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8410304
[patent_doc_number] => 08273701
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-25
[patent_title] => 'Method for diagnosing non-small cell lung carcinoma'
[patent_app_type] => utility
[patent_app_number] => 12/063781
[patent_app_country] => US
[patent_app_date] => 2006-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8596
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12063781
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/063781 | Method for diagnosing non-small cell lung carcinoma | Aug 13, 2006 | Issued |
Array
(
[id] => 5051328
[patent_doc_number] => 20070031873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Predicting bone relapse of breast cancer'
[patent_app_type] => utility
[patent_app_number] => 11/497180
[patent_app_country] => US
[patent_app_date] => 2006-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18074
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20070031873.pdf
[firstpage_image] =>[orig_patent_app_number] => 11497180
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/497180 | Predicting bone relapse of breast cancer | Jul 31, 2006 | Abandoned |
Array
(
[id] => 5602895
[patent_doc_number] => 20060293240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'Human Sef isoforms and methods of using same for cancer diagnosis and gene therapy'
[patent_app_type] => utility
[patent_app_number] => 11/493608
[patent_app_country] => US
[patent_app_date] => 2006-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 32613
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20060293240.pdf
[firstpage_image] =>[orig_patent_app_number] => 11493608
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/493608 | Human Sef isoforms and methods of using same for cancer diagnosis and gene therapy | Jul 26, 2006 | Issued |
Array
(
[id] => 162895
[patent_doc_number] => 07671183
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-02
[patent_title] => 'PAAD domain-containing polypeptides, encoding nucleic acids, and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/496017
[patent_app_country] => US
[patent_app_date] => 2006-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 36222
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/671/07671183.pdf
[firstpage_image] =>[orig_patent_app_number] => 11496017
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/496017 | PAAD domain-containing polypeptides, encoding nucleic acids, and methods of use | Jul 26, 2006 | Issued |
Array
(
[id] => 303293
[patent_doc_number] => 07534429
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-19
[patent_title] => 'Cytotoxicity mediation of cells evidencing surface expression of CD63'
[patent_app_type] => utility
[patent_app_number] => 11/493407
[patent_app_country] => US
[patent_app_date] => 2006-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 21933
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/534/07534429.pdf
[firstpage_image] =>[orig_patent_app_number] => 11493407
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/493407 | Cytotoxicity mediation of cells evidencing surface expression of CD63 | Jul 25, 2006 | Issued |
| 11/490374 | Colon disease targets and uses thereof | Jul 20, 2006 | Abandoned |
Array
(
[id] => 318486
[patent_doc_number] => 07521195
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2009-04-21
[patent_title] => 'Lung disease targets and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/490329
[patent_app_country] => US
[patent_app_date] => 2006-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43123
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/521/07521195.pdf
[firstpage_image] =>[orig_patent_app_number] => 11490329
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/490329 | Lung disease targets and uses thereof | Jul 20, 2006 | Issued |
Array
(
[id] => 5297098
[patent_doc_number] => 20090012024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Stem Cell Markers'
[patent_app_type] => utility
[patent_app_number] => 11/996839
[patent_app_country] => US
[patent_app_date] => 2006-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 20002
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20090012024.pdf
[firstpage_image] =>[orig_patent_app_number] => 11996839
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/996839 | Stem Cell Markers | Jul 18, 2006 | Abandoned |
Array
(
[id] => 7555252
[patent_doc_number] => 08067153
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-29
[patent_title] => 'Genes and polypeptides relating to prostate cancers'
[patent_app_type] => utility
[patent_app_number] => 11/913233
[patent_app_country] => US
[patent_app_date] => 2006-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 24975
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/067/08067153.pdf
[firstpage_image] =>[orig_patent_app_number] => 11913233
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/913233 | Genes and polypeptides relating to prostate cancers | Jul 18, 2006 | Issued |
Array
(
[id] => 4839811
[patent_doc_number] => 20080280297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-13
[patent_title] => 'Compositions and Methods for Differential Diagnosis of Chronic Lymphocytic Leukemia'
[patent_app_type] => utility
[patent_app_number] => 11/995719
[patent_app_country] => US
[patent_app_date] => 2006-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 19223
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20080280297.pdf
[firstpage_image] =>[orig_patent_app_number] => 11995719
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/995719 | Compositions and Methods for Differential Diagnosis of Chronic Lymphocytic Leukemia | Jul 16, 2006 | Abandoned |
Array
(
[id] => 6625769
[patent_doc_number] => 20100034840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE TO ESCAPE MUTANTS OF TARGETED THERAPIES'
[patent_app_type] => utility
[patent_app_number] => 12/067802
[patent_app_country] => US
[patent_app_date] => 2006-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29699
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20100034840.pdf
[firstpage_image] =>[orig_patent_app_number] => 12067802
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/067802 | COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE TO ESCAPE MUTANTS OF TARGETED THERAPIES | Jul 9, 2006 | Abandoned |
Array
(
[id] => 5106571
[patent_doc_number] => 20070065448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Methods and compositions for treating diseases targeting MABA1'
[patent_app_type] => utility
[patent_app_number] => 11/481045
[patent_app_country] => US
[patent_app_date] => 2006-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 32281
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20070065448.pdf
[firstpage_image] =>[orig_patent_app_number] => 11481045
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/481045 | Methods and compositions for treating diseases targeting MABA1 | Jul 5, 2006 | Abandoned |
Array
(
[id] => 4995109
[patent_doc_number] => 20070010454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-11
[patent_title] => 'Method for treating tumor cells resulting in minimal liver toxicity'
[patent_app_type] => utility
[patent_app_number] => 11/456026
[patent_app_country] => US
[patent_app_date] => 2006-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3812
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20070010454.pdf
[firstpage_image] =>[orig_patent_app_number] => 11456026
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/456026 | Method for treating tumor cells resulting in minimal liver toxicity | Jul 5, 2006 | Abandoned |
Array
(
[id] => 5189096
[patent_doc_number] => 20070167405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'Galectins -1 and -4 in tumor development'
[patent_app_type] => utility
[patent_app_number] => 11/481706
[patent_app_country] => US
[patent_app_date] => 2006-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7387
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20070167405.pdf
[firstpage_image] =>[orig_patent_app_number] => 11481706
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/481706 | Galectins -1 and -4 in tumor development | Jul 4, 2006 | Abandoned |
Array
(
[id] => 6443031
[patent_doc_number] => 20100038247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-18
[patent_title] => 'Electrode Assembly, Use Thereof, and Method for the Production Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/922971
[patent_app_country] => US
[patent_app_date] => 2006-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11218
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20100038247.pdf
[firstpage_image] =>[orig_patent_app_number] => 11922971
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/922971 | Electrode Assembly, Use Thereof, and Method for the Production Thereof | Jul 2, 2006 | Abandoned |
Array
(
[id] => 5050874
[patent_doc_number] => 20070031419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Methods and compositions for treating diseases targeting CDCP1'
[patent_app_type] => utility
[patent_app_number] => 11/476141
[patent_app_country] => US
[patent_app_date] => 2006-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 36060
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20070031419.pdf
[firstpage_image] =>[orig_patent_app_number] => 11476141
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/476141 | Methods and compositions for treating diseases targeting CDCP1 | Jun 27, 2006 | Abandoned |
Array
(
[id] => 6326614
[patent_doc_number] => 20100197561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'Biomarkers for Ovarian Cancer: B2 Microglobulin'
[patent_app_type] => utility
[patent_app_number] => 11/922621
[patent_app_country] => US
[patent_app_date] => 2006-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17153
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20100197561.pdf
[firstpage_image] =>[orig_patent_app_number] => 11922621
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/922621 | Biomarkers for Ovarian Cancer: B2 Microglobulin | Jun 22, 2006 | Abandoned |
Array
(
[id] => 5219306
[patent_doc_number] => 20070160617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-12
[patent_title] => 'PSMA antibody-drug conjugates'
[patent_app_type] => utility
[patent_app_number] => 11/471457
[patent_app_country] => US
[patent_app_date] => 2006-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 23163
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20070160617.pdf
[firstpage_image] =>[orig_patent_app_number] => 11471457
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/471457 | PSMA antibody-drug conjugates | Jun 19, 2006 | Abandoned |
Array
(
[id] => 6636521
[patent_doc_number] => 20100173788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'BIOMARKERS FOR BREAST CANCER'
[patent_app_type] => utility
[patent_app_number] => 11/917766
[patent_app_country] => US
[patent_app_date] => 2006-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18702
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20100173788.pdf
[firstpage_image] =>[orig_patent_app_number] => 11917766
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/917766 | BIOMARKERS FOR BREAST CANCER | Jun 19, 2006 | Abandoned |
Array
(
[id] => 5142446
[patent_doc_number] => 20070004662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma'
[patent_app_type] => utility
[patent_app_number] => 11/454616
[patent_app_country] => US
[patent_app_date] => 2006-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13043
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20070004662.pdf
[firstpage_image] =>[orig_patent_app_number] => 11454616
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/454616 | Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma | Jun 15, 2006 | Issued |